MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

FDA approves Medtronic renal denervation trial in on-med patients

November 8, 2018 By Brad Perriello Leave a Comment

Medtronic (NYSE:MDT) said today that the FDA approved a clinical trial of its Symplicity Spyral renal denervation device in patients who already take medication for their high blood pressure. Fridley, Minn.-based Medtronic said the three-year, 340-patient Spyral HTN-On Med sham-controlled study is designed to compare treatment with the Symplicity Spyral device and a sham procedure, randomized […]

Filed Under: Clinical Trials, Featured, Vascular Tagged With: Hypertension, Medtronic, Renal

Vascular Dynamics launches pivotal trial for MobiusHD hypertension device

September 5, 2018 By Brad Perriello Leave a Comment

Vascular Dynamics said yesterday that it launched a pivotal trial of its MobiusHD device to treat high blood pressure ahead of a bid for a nod from the FDA. The MobiusHD device is designed to help regulate blood pressure by reshaping the the carotid artery to stimulate baroreceptors and increase the body’s natural response to lower blood […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: Hypertension, vasculardynamics

Otsuka to acquire renal denervation firm ReCor Medical

July 10, 2018 By Brad Perriello Leave a Comment

Otsuka Holdings (TYO:4578) said today that it plans to acquire the remaining stake it doesn’t already own in ReCor Medical and the renal denervation device it’s developing to treat hypertension. Tokyo-based Otsuka led ReCor’s $15 million Series D in April 2015 to back Palo Alto, Calif.- and Amsterdam-based ReCor’s Radiance-HTN study, which will test its Paradise system in patients […]

Filed Under: Mergers & Acquisitions, Ultrasound, Wall Street Beat Tagged With: Hypertension, Otsuka Holdings, ReCor Medical, Renal

ReCor Medical adds another $12m for trial of Paradise renal denervation device

August 16, 2017 By Brad Perriello Leave a Comment

ReCor Medical last week added a $12 million contribution from Otsuka Pharmaceutical (TYO:4578) to the $10 million it raised from the Japanese conglomerate last year for a clinical trial of its Paradise renal denervation device for treating hypertension, ReCor president & CEO Andrew Weiss told MassDevice.com this morning. In May 2016 Otsuka participated in a strategic investment of an unspecified amount; […]

Filed Under: Clinical Trials, Funding Roundup, Wall Street Beat Tagged With: Hypertension, ReCor Medical

Vascular Dynamics raises $10m for MobiusHD

March 31, 2017 By Brad Perriello Leave a Comment

Vascular Dynamics said this week that it closed a private placement worth $10.4 million that it plans to use on the clinical program for its MobiusHD device for treating drug-resistant hypertension. The MobiusHD implant is designed to reshape the carotid sinus to amplify the signals for baroreceptors lining the blood vessel. Implanted percutaneously, it’s designed to stimulate vasodilation. […]

Filed Under: Cardiovascular, Funding Roundup Tagged With: Hypertension, vasculardynamics

SteadyMed details commercialization plans for Trevyent

October 18, 2016 By Sarah Faulkner Leave a Comment

SteadyMed Therapeutics (NSDQ:STDY) today detailed the development of its lead drug product candidate, Trevyent (treprostinil sodium), for the treatment of pulmonary arterial hypertension using its PatchPump tech at the Parenteral Drug Assn. Conference in Huntington Beach, Calif. PatchPump is the 1st single-use, wearable, pre-filled pump and treprostinil will be the 1st drug integrated with the delivery system, according to […]

Filed Under: Drug-Device Combinations, Research & Development Tagged With: Hypertension, SteadyMed Therapeutics

Ablative Solutions wins FDA nod for Phase II chemical denervation trial

September 13, 2016 By Sarah Faulkner Leave a Comment

Ablative Solutions said today that the FDA approved a Phase II trial of its chemical denervation system for hypertension under its investigational new drug application. The trial, called Target-BP I, will evaluate the efficacy of Ablative’s Peregrine infusion ablation system, which uses ethanol to interrupt signals from sympathetic nerves in the renal artery to control […]

Filed Under: Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA) Tagged With: Ablative Solutions, Hypertension, Medtronic, stjudemedical

Rox Medical raises $40m Series E for hypertension ‘stent’

September 6, 2016 By Brad Perriello Leave a Comment

Rox Medical said today that it raised a $40 million Series E round for the stent-like Coupler device it developed to treat hypertension by connecting the femoral artery and the femoral vein. The round was led by the Novartis Venture Fund and Apple Tree Partners, with participation from prior backers Versant Ventures and Domain Associates, San Clemente, Calif.-based Rox said. […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Hypertension, Rox Medical

Renal Dynamics launches post-market trial for Redy 3rd-gen renal denervation device

May 17, 2016 By Brad Perriello Leave a Comment

Renal Dynamics said it launched a post-market study of its Redy renal denervation device for treating hypertension, after winning CE Mark approval for the device last November. Zug, Switzerland-based Renal Dynamics, which is owned by the Hobart Group, said the 1st patient in the trial was successfully treated at Novosibirsk, Russia’s Meshalkin State Research Institute of Circulation Pathology. […]

Filed Under: Catheters, Clinical Trials, Vascular Tagged With: Hypertension, Renal Dynamics

ReCor Medical launches trial for Paradise renal denervation device

April 7, 2016 By Brad Perriello Leave a Comment

ReCor Medical said today that it’s enrolled the 1st patients in the 292-patient Radiance-HTN study of its Paradise renal denervation device for treating hypertension. The blinded, randomized and sham-controlled trial is designed to evaluate the Paradise system in patients with essential hypertension taking 2 or fewer medications and patients with treatment-resistant hypertension on a minimum of 3 drugs. The trial […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: Hypertension, ReCor Medical, Renal

ReCor Medical to launch U.S. trial for Paradise renal denervation device

February 22, 2016 By Brad Perriello Leave a Comment

ReCor Medical said today that it won an investigation device exemption from the FDA for a clinical trial of its Paradise renal denervation device for treating high blood pressure. Palo Alto, Calif., and Amsterdam-based ReCor said the 292-patient Radiance-HTN study, a blinded, randomized and sham-controlled trial, is designed to evaluate the Paradise system in patients with essential hypertension […]

Filed Under: Clinical Trials, Vascular Tagged With: Hypertension, ReCor Medical, Renal

  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS